References
Ricklefs R.E., Finch C.E.: Aging, A Natural History. Scientific Scientific American Library, New York, 1995, pp. 1–209.
Rose M.R.: Evolutionary Biology of Aging. Oxford University Press, New York, 1991, pp. 3–221.
Yates F.E.: Theories of Aging: Biological. In: Birren J. E. (Ed.), Encyclopedia of Gerontology, Vol. 2. Academic Press, San Diego, 1996, pp. 545–555.
Piantanelli L., Basso A., Rossolini G.: Modelling the link between aging rate and mortality rate. Ann. N. Y. Acad. Sci. 719: 136–145, 1994.
Rowe J.W., Kahn R.L.: Human aging: Usual and successful. Science 237: 143–149, 1987.
Borkan G.A., Norris A.H.: Assessment of biological age using a profile of physical parameters. J. Gerontol. 35: 177–184, 1980.
McClearn G.E.: Biomarkers of age and aging. Exp. Gerontol. 32: 87–94, 1997.
Johnson T.E., Lithgow G.J., Murakami S., Shook D.R.: Genetics. In: Birren J.E. (Ed.), Encyclopedia of Gerontology, Vol. 1. Academic Press, San Diego, 1996, pp. 577–586.
Finch C.E.: Longevity, Senescence, and the Genome. University of Chicago Press, Chicago, 1990, pp. 1–922.
References
Goldstein S.: Replicative senescence: the human fibroblast comes of age. Science 249: 1129–1133, 1990.
Ponten J.: The relationship between in vitro transformation and tumor formation in vivo. Biochim. Biophys. Acta 458: 397–422, 1976.
Smith J.R., Pereira-Smith O.M.: Replicative senescence: implications for in vivo aging and tumor suppression. Science 273: 63–67, 1996.
Stein G.H., Beeson M., Gordon L.: Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249: 666–669, 1990.
Pang J.H., Chen K.Y.: Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J. Cell. Physiol. 160: 531–538, 1994.
Pereira-Smith O.M., Smith J.R.: Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl. Acad. Sci. USA 85: 6042–6046, 1988.
O’Brian W., Stenman G., Sager R.: Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc. Natl. Acad. Sci. USA 83: 8659–8663, 1986.
Kubbies M., Schindler D., Hoehn H., Rabinovitch P.S.: BrdU-Hoechst flow cytometry reveals regulation of human lymphocyte growth by donor-age-related growth fraction and transition rate. J. Cell. Physiol. 125: 229–234, 1985.
References
Cochran W.G., Cox G.M.: Experimental Designs. John Wiley & Sons, New York, 1957.
Weindruch R., Walford R.L.: The Retardation of Aging and Disease by Dietary Restriction. Charles C. Thomas, Springfield, 1988.
Kirkwood B.R.: Essentials of Medical Statistics. Blackwell Scientific, Oxford, 1988.
Olde Rikkert M.G.M., van’t Fof M.A., Hoefnagels W.H.L.: Dispersion measures in biomedical research on ageing: nuances in the meaning of variability. Age Ageing 26: 45–52, 1997.
Diggle P.J.: Time Series: A Biostatistical Introduction. Clarendon Press, Oxford, 1990.
Tower J.: Aging mechanisms in fruit flies. Bioessays 18: 799–807, 1996.
Kaiser M., Gasser M., Ackermann R., Stearns S.C.: P-element inserts in transgenic flies, a cautionary tale. Heredity 78: 1–11, 1997.
Chapman T., Liddle L.F., Kalb J.M., Wolfner M.F., Partridge L.: Cost of mating in Drosophila melanogaster females is mediated by male accessory gland products. Nature 373: 241–244, 1995.
References
Jazwinski S.M.: Longevity, genes, and aging. Science 273: 54–59, 1996.
Hazzard D.G.: Relevance of the rodent model to human aging studies. Neurobiol. Aging 12: 645–649, 1991.
Hazzard D.G., Bronson R.T., McClearn G.E., Strong R.: Selection of an appropriate animal model to study aging processes with special emphasis on the use of rat strains. J. Gerontol. 47: B63–B64, 1992.
Weindruch R., Masoro E.J.: Concerns about rodent models for aging research. J. Gerontol. 46: B87–B88, 1991.
Masoro E.J.: Use of rodents as models for the study of “normal aging”: Conceptual and practical issues. Neurobiol. Aging 12: 639–643, 1991.
Phelan J.P., Austad S.N.: Selecting animal models of human aging: Inbred strains often exhibit less biological uniformity than F1 hybrids. J. Gerontol. 49: B1–B11, 1994.
McCay C.M., Crowell M.F., Maynard L.A.: The effect of retarded growth upon the length of life span and upon the ultimate body size. J. Nutr. 10: 63–79, 1935.
McCarter R.J., Palmer J.: Energy metabolism and aging: a lifelong study of Fischer 344 rats. Am. J. Physiol. 263: E448–E452, 1992.
Harrison D.E., Archer J.R., Astole C.M.: Effects of food restriction on aging: separation of food intakes and adiposity. Proc. Natl. Acad. Sci. USA 81: 1835–1838, 1984.
Yu B.P., Masoro E.J., McMahan C.A.: Nutritional influences on aging of Fischer 344 rats. I. Physical, metabolic, and longevity characteristics. J. Gerontol. 40: 657–670, 1985.
References
Hayflick L., Moorhead P.S: The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585–621, 1961.
Hayflick L.: The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614–636, 1965.
Cristofalo V.J., Pignolo R.J.: Cell culture as a model. In: Masoro E.J., (Ed.), Handbook of Physiology — Aging. Oxford University Press, New York, 1995, pp. 53–82.
Macieira-Coelho A., Ponten J., Phillipson L.: The division cycle and RNA synthesis in diploid human cells at different passage levels in vitro. Exp. Cell Res. 42: 673–684, 1966.
Cristofalo V.J., Sharf B.B.: Cellular senescence and DNA synthesis: thymidine incorporation as a measure of population age in human diploid cells. Exp. Cell Res. 76: 419–427, 1973.
Yanishevsky R., Mendelsohn M.L., Mayall B.H., Cristofalo V.J.: Proliferative capacity and DNA content of aging human diploid cells in culture: a cytophotometric and autoradiographic analysis. J. Cell. Physiol. 84: 165–170, 1974.
Phillips P.D., Kaji K., Cristofalo V.J.: Progressive loss of the response of senescing WI-38 cells to platelet-derived growth factor, epidermal growth factor, insulin, transferrin, and dexamethasone. J. Gerontol. 39: 11–17, 1984.
Seshadri T., Campisi J.: Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247: 205–209, 1990.
De Tata V., Ptasznik A., Cristofalo V.J.: Effects of the tumor promoting agent phorbol 12-myristate 13-acetate (PMA) on the proliferation of young and senescent WI-38 human diploid fibroblasts. Exp. Cell Res. 205: 261–269, 1993.
Norwood T.H., Pendergrass W.R., Sprague C.A., Martin G.M.: Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. Proc. Natl. Acad. Sci. USA 71: 2231–2235, 1974.
Lumpkin C.K.J., McClung J.K., Pereira-Smith O.M., Smith J.R.: Existence of high abundance antiproliferative mRNAs in senescent human diploid fibroblasts. Science 232: 393–395, 1986.
Campisi J., Dimri G., Hara E.: Control of replicative senescence. In: Schneider E.L., Rowe J.W. (Eds.), Handbook of the Biology of Aging, ed. 4. Academic Press Inc., San Diego, 1996, pp. 121–149.
References
Morgenstern H., Kleinbaum D.G., Kupper L.L.: Measures of disease incidence used in epidemiologic research. Int. J. Epidemiol. 9: 97–104, 1980.
Murray C.J.L., Lopez A.D.: Evidence-based health policy. Lessons from the Global Burden of Disease Study. Science 274: 740–743, 1996.
The World Bank: World Development Report 1993. Oxford University Press, New York, 1993, pp. 1–36.
Wolfson M.C.: Health-adjusted life expectancy. Health Rep. 8: 41–46, 1996.
Maggi S., Zucchetto M., Grigoletto F., Baldereschi M., Candelise L., Scarpini E., Scarlato G., Amaducci L., for the ILSA Group: The Italian Longitudinal Study on Aging (ILSA): Design and methods. Aging Clin. Exp. Res. 6: 464–473, 1994.
The Italian Longitudinal Study on Aging (ILSA) Working Group: Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int. J. Epidemiol. 26: 995–1002, 1997.
References
Roberts J., Tumer N.: Pharmacodynamic basis for altered drug action in the elderly. Clin. Geriatr. Med. 4:127–148, 1988.
Tumer N., Scarpace P.J., Lowenthal D.T.: Geriatric pharmacology: Basic and clinical considerations. Annu. Rev. Pharmacol. Toxicol. 32: 271–302, 1992.
Eddington N.: Pharmacokinetics. In: Roberts J., Snyder D., Friedman E. (Eds.), Handbook on Pharmacology of Aging, ed. 2. CRC Press, Boca Raton, 1996.
Abernethy D.R.: Altered pharmacodynamics of cardiovascular drugs and their relation to altered pharmacokinetics in elderly patients. Clin. Geriatr. Med. 6: 285–292, 1990.
Tsujimoto G., Hashimoto K., Hoffman B.B.: Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 2. Int. J. Clin. Pharmacol. Ther. 27: 102–116, 1989.
Lamy P.P.: Adverse drug effects. Clin. Geriatr. Med. 6: 293–307, 1990.
Cadieux R.J.: Drug interactions in the elderly: how multiple drug use increases risk exponentially. Postgrad. Med. 86: 179–186, 1989.
Roberts J., Tumer N.: Age and diet effects on drug action. Pharmacol. Ther. 37: 111–149, 1988.
Nolan L., O’Malley K.: Adverse effects of antidepressants in the elderly. Drugs Aging 2: 450–458, 1992.
Harrington C., Tompkins C., Curtis M., Grant L.: Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 6: 822–833, 1992.
Girgis L., Brooks P.: Nonsteroidal anti-inflammatory drugs, differential use in older patients. Drugs Aging 4: 101–112, 1994.
Willcox S.M., Himmelstein D.U., Woolhandler S.: Inappropriate drug prescribing for the community-dwelling elderly. JAMA 272: 292–296, 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masoro, E.J., Smith, J.R., Kirkwood, T.B.L. et al. “Advanced Summer School on Pathobiology of Aging” — First Course. Aging Clin Exp Res 9, 436–446 (1997). https://doi.org/10.1007/BF03339626
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03339626